Literature DB >> 3139669

Biosynthesis of heparin. O-sulfation of the antithrombin-binding region.

M Kusche1, G Bäckström, J Riesenfeld, M Petitou, J Choay, U Lindahl.   

Abstract

The antithrombin-binding region in heparin is a pentasaccharide sequence with the predominant structure GlcNAc(6-OSO3)-GlcA-GlcNSO3(3,6-di-OSO3)-IdoA -(2-OSO3)-GlcNSO3(6-OSO3) (where GlcA and IdoA represent D-glucuronic and L-iduronic acid, respectively), in which the 3-O-sulfate residue on the internal glucosaminyl unit is a marker group for this particular region of the polysaccharide molecule. A heparin octasaccharide which contained the above pentasaccharide sequence was N/O-desulfated and re-N-sulfated and was then incubated with adenosine 3'-phosphate 5'-phospho[35S]sulfate in the presence of a microsomal fraction from mouse mastocytoma tissue. Fractionation of the resulting 35S-labeled octasaccharide on antithrombin-Sepharose yielded a high affinity fraction that accounted for approximately 2% of the total incorporated label. Structural analysis of this fraction indicated that the internal glucosamine unit of the pentasaccharide sequence was 3-O-35S-sulfated, whereas both adjacent glucosamine units carried 6-O-[35S]sulfate groups. In contrast, the fractions with low affinity for antithrombin (approximately 98% of incorporated 35S) showed no consistent O-35S sulfation pattern and essentially lacked glucosaminyl 3-O-[35S]sulfate groups. It is suggested that the 3-O-sulfation reaction concludes the formation of the antithrombin-binding region. This proposal was corroborated in a similar experiment using a synthetic pentasaccharide with the structure GlcNSO3(6-OSO3)-GlcA-GlcNSO3(6-OSO3)-Id oA (2-OSO3)-GlcNSO3(6-OSO3) as sulfate acceptor. This molecule corresponds to a functional antithrombin-binding region but for the lack of a 3-O-sulfate group at the internal glucosamine unit. The 35S-labeled pentasaccharide recovered after incubation bound with high affinity to antithrombin-Sepharose and contained a 3-O-[35S]sulfate group at the internal glucosamine residue as the only detectable labeled component. The use of this pentasaccharide substrate along with the affinity matrix provides a highly specific assay for the 3-O-sulfotransferase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139669

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Molecular-size-dependent variations in the proportions of chains with high binding affinities for antithrombin in rat skin heparin proteoglycans.

Authors:  A A Horner
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

2.  Biosynthesis of heparin. Relationship between the polymerization and sulphation processes.

Authors:  K Lidholt; L Kjellén; U Lindahl
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

3.  Chemical Tumor Biology of Heparan Sulfate Proteoglycans.

Authors:  Karthik Raman; Balagurunathan Kuberan
Journal:  Curr Chem Biol       Date:  2010-01-01

Review 4.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

Review 5.  Heparan sulfate 3-O-sulfation: a rare modification in search of a function.

Authors:  Bryan E Thacker; Ding Xu; Roger Lawrence; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2013-12-19       Impact factor: 11.583

6.  Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions.

Authors:  M Kusche; H H Hannesson; U Lindahl
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

7.  Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence.

Authors:  Sophia Schedin-Weiss; Benjamin Richard; Rebecka Hjelm; Steven T Olson
Journal:  Biochemistry       Date:  2008-12-23       Impact factor: 3.162

8.  Biosynthesis of heparin. The D-glucuronosyl- and N-acetyl-D-glucosaminyltransferase reactions and their relation to polymer modification.

Authors:  K Lidholt; U Lindahl
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

9.  Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties.

Authors:  Christian Viskov; Stefano Elli; Elena Urso; Davide Gaudesi; Pierre Mourier; Frederic Herman; Christian Boudier; Benito Casu; Giangiacomo Torri; Marco Guerrini
Journal:  J Biol Chem       Date:  2013-07-10       Impact factor: 5.157

10.  Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide.

Authors:  N Razi; E Feyzi; I Björk; A Naggi; B Casu; U Lindahl
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.